Immune dysregulation in atopic dermatitis

Allergy and Asthma Proceedings

Volumn 27, Issue 6, 2006, Pages 451-455

  Del Giudice, Michele Miraglia ^a,b,d   Decimo, Fabio ^a,c   Leonardi, Salvatore ^a,b   Maioello, Nunzia ^a,b   Amelio, Raffaele ^a,b   Capasso, Antonella ^a,b   Capristo, Carlo ^a,b   Capristo, Angelo F ^a,b  

^a II University of Naples ^*

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Pediatric Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ATOPIC DERMATITIS; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; DERMATITIS, ATOPIC; HUMANS;

EID: 33845503716     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2887     Document Type: Review

References (37)

1. Leung DY, and Bieber T. Atopic dermatitis. Lancet 361:151-160, 2003.
2. Ring J, Kramer U, Schafer T, et al. Why are allergies increasing? Curr Opin Immunol 13:701-708, 2001.
3. Van Bever HP. Early events in atopy. Eur J Pediatr 161:542-546, 2002.
4. Williams HC. Atopic dermatitis. N Engl J Med 352:2314-2324, 2005.
5. Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 49:1088-1095, 2003.
6. Leung DY. Atopic dermatitis: New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105:860-876, 2000.
7. Spergel JM, and Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:8118-5127, 2003.
8. Novak N, and Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112:252-262, 2003.
9. Chamlin SL, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47:198-208, 2002.
10. Leung YM, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 113:651-657, 2004.
11. Esche C, De Benedetto A, et al. Keratinocytes in atopic dermatitis: Inflammatory signals. Curr Allergy Asthma Rep 4:276-284, 2004.
12. Novak N, et al. Unraveling the mission of FCεRI on APCs. J All Clin Immunol 111:38-44, 2003.
13. von Bubnoff D, Geiger E, and Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol 108:329-339, 2001.
14. Novak N, Bieber T, and Leung DY. Immune mechanism leading to atopic dermatitis. J Allergy Clin Immunol 112:S128-S139, 2003.
15. Langeveld-Wildschut EG, et al. Clinical and immunological variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol 105:1008-1016, 2000.
16. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25 + regulatory T-cell suppression of allergen driven T-cell activation to atopic status and expression of allergic disease. Lancet 363:608-615, 2004.
17. Toda M, et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111:875-881, 2003.
18. Blauvelt A, Hwang ST, and Udey MC. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 111:S560-S570, 2003.
19. Beyer K. Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J Invest Dermatol 115:906-908, 2000.
20. Nickel R, Lau S, Niggemann B, et al. MAS Group-Messages from the German Multicentre Allergy Study. Pediatr Allergy Immunol 13:S7-S10, 2002.
21. Cookson WOC. Asthma genetics. Chest 121:S7-S13, 2002.
22. Bowcock AM, and Cookson WO. The genetics of psoriasis, psoriatic arthritis, and atopic dermatitis. Hum Mol Genet 13: R43-R55, 2004.
23. Ochs RL, Muro Y, Si Y, et al. Autoantibodies to DSF 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 105:1211-1220, 2000.
24. Valenta R, Seiberler S, Natter S, et al. Autoallergy: A pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 105: 432-437, 2000.
25. Kinaciyan T, Natter S, Kraft D, et al. IgE autoantibodies monitore in patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J Allergy Clin Immunol 109:717-719, 2002.
26. Pallanti S, Lotti T, and Urpe M. Psychoneuroimmunodermatology of atopic dermatitis: From empiric data to the evolutionary hypothesis. Dermatol Clin 23:695-701, 2005.
27. Raap U, Werfel T, Jaeger B, et al. Atopic dermatitis and psychological stress. Hautarzt 54:925-929, 2003.
28. + T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 107:171-177, 2001.
29. Lin YT, Shau WY, Wang LF, et al. Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis. Allergy 55:641-646, 2000.
30. Ou LS, Goleva E, Hall C, et al. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clinical Immunol 113:756-763, 2004.
31. Mayser P, and Gross A. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens. Acta Derm Venereol 80:357-361, 2000.
32. Ellis C, Luger T, Abeck D, et al. International Consensus Conference on atopic dermatitis II (ICCAD II): Clinical update and current treatment strategies. Br J Dermat 148:3-10, 2003.
33. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 59:86-92, 2004.
34. Alomar A, Berth-Jones J, Bos JD, et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151:3-27, 2004.
35. Hultsch T, Kapp A, and Spergel J. Immunomodulation and safety of topical Calcineurin Inhibitors for the treatment of atopic dermatitis. Dermatology 211:174-187, 2005.
36. Ashcroft DM, Dimmock P, Garside R, et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials. BMJ 330:516, 2005.
37. Fonacier L, Spergel J, Charlesworth EN, et al. Report of Topical Calcineurin inhibitor Task Force of The American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 115:1249-1253, 2005.